Overview
Investors 7
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| SJF Ventures | sjfventures.com | |
| Health Catalyst Capital Management | healthcatalystcapital.com | |
| ATW Partners | atwpartners.com | |
| OrbiMed | orbimed.com | |
| Healthbox | healthbox.com | |
| Intermountain Ventures | intermountainventures.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Oct 28, 2019 | Series B round | $27M | |
| Jan 7, 2016 | Series A round | $9.25M |
Mentions in press and media 21
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 7, 2022 | Pierian Selected by PreCheck Health Services to Support Hereditary Cancer Testing for Providers and Patients | Pierian, a global leader in advanced clinical genomics technology and services, announced a collaboration to support PreCheck Health Services, a CLIA-registered, CAP-accredited high complexity laboratory, in providing cancer-related genomic... |
| Nov 2, 2021 | PierianDx Closes up to $47.5 Million of Growth Capital | |
| Nov 2, 2021 | PierianDx Closes up to $47.5 Million of Growth Capital | PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to $17.5 mil... |
| Mar 2, 2021 | PierianDx Announces the Appointment of Lindsay Mateo as Chief Business Officer | ST. LOUIS--(BUSINESS WIRE)--Mar 2, 2021-- PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinfo... |
| Oct 28, 2019 | PierianDx raises $27M in Series B to ‘democratize’ next-generation sequencing | “PierianDx has grown tremendously over the past 18 months and is continuing to add the clinical expertise and resources necessary to execute on our vision,” PierianDx Executive Chairman Rakesh Nagarajan said in a statement. “Our team is uni... |
| Oct 28, 2019 | PierianDx Closes $27M Series B Financing | PierianDx, a St. Louis-based clinical genomics informatics company, closed a $27m Series B funding round. The round was led by ATW Partners and SJF Ventures with participation from existing investors Health Catalyst Capital, Inova Health Sy... |
| Oct 17, 2017 | Cleveland Clinic Joins PierianDx’s Customer Network to Accelerate Precision Medicine | ST. LOUIS–(BUSINESS WIRE)–October 17, 2017– PierianDx announced today that Cleveland Clinic will utilize its integrated “one space” workflow and analysis solution, Clinical Genomicist Workspace (CGW), to advance precision medicine for patie... |
| Apr 6, 2017 | Intermountain Healthcare Innovation Fund gives some more love to Redox | Healthbox has previously run an accelerator for healthcare startups called Healthbox Studio but with the management change last year, Healthbox repositioned itself as a venture capital investment manager with an innovation platform that fun... |
| Mar 3, 2017 | PierianDx’s Partner Sharing Network Achieves Critical Mass with New Wave of Customers Adopting Clinical Genomicist Workspace (CGW) | ST. LOUIS–(BUSINESS WIRE)–March 3, 2017– PierianDx announced today that six leading healthcare systems and academic medical centers have chosen its leading “One Space” genomics software solution, CGW, to streamline clinical lab workflow, an... |
Reviews 0
FAQ about PierianDx
When was PierianDx founded?
PierianDx was founded in 2014.
How much funding has PierianDx raised?
PierianDx has raised $83.75M in total across 3 funding rounds.
What funding rounds has PierianDx raised?
Parsers VC lists 3 funding rounds of PierianDx, among them a Series B round of $27M on Oct 28, 2019 and a Series A round of $9.25M on Jan 7, 2016.
Who has invested in PierianDx?
Parsers VC lists 7 investors of PierianDx, among them SJF Ventures, Health Catalyst Capital Management and ATW Partners.
What has the press written about PierianDx?
Parsers VC has collected 21 articles mentioning PierianDx, among them “Pierian Selected by PreCheck Health Services to Support Hereditary Cancer Testing for Providers and Patients” (Dec 7, 2022) and “PierianDx Closes up to $47.5 Million of Growth Capital” (Nov 2, 2021).
Is PierianDx still active?
Yes, PierianDx is active; its latest activity on Parsers VC dates from Jan 13, 2023.